Published 30 days ago

Atara Biotherapeutics Sees Its Stock Price Rise

Summary by labusinessjournal.com

The announcement by Atara Biotherapeutics Inc. that it was raising $36 million through a registered direct offering sat well with investors. Thousand Oaks-based drug company made the announcement after the market closed on Sept. 3. The following day the stock rose nearly 33% to end the day at $9.05. The increase in share price continued a trend of sorts in play for Atara since its 1:25 stock split on June 20. On that day the share price closed a…

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right

Coverage Details

Total News Sources0

Leaning Left0Leaning Right0Center0Last Updated30 days agoBias Distribution

No sources with tracked biases.

Bias Distribution

There is no tracked Bias information for the sources covering this story.

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)

Atara Biotherapeutics Sees Its Stock Price Rise

Coverage Details

Bias Distribution

Ownership

Similar News Topics

Similar News Topics